Field Trip Health Ltd
TSX:FTRP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Field Trip Health Ltd
Cash & Cash Equivalents
Field Trip Health Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Field Trip Health Ltd
TSX:FTRP
|
Cash & Cash Equivalents
CA$63.7m
|
CAGR 3-Years
374%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
71%
|
|
|
A
|
Andlauer Healthcare Group Inc
TSX:AND
|
Cash & Cash Equivalents
CA$59m
|
CAGR 3-Years
26%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
WELL Health Technologies Corp
TSX:WELL
|
Cash & Cash Equivalents
CA$133.8m
|
CAGR 3-Years
40%
|
CAGR 5-Years
9%
|
CAGR 10-Years
79%
|
|
|
dentalcorp Holdings Ltd
TSX:DNTL
|
Cash & Cash Equivalents
CA$79.5m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lithos Energy Ltd
CNSX:LITS
|
Cash & Cash Equivalents
CA$21.2k
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Healwell Al Inc
TSX:AIDX
|
Cash & Cash Equivalents
CA$18.6m
|
CAGR 3-Years
136%
|
CAGR 5-Years
84%
|
CAGR 10-Years
N/A
|
|
Field Trip Health Ltd
Glance View
Field Trip Health Ltd. engages in development and delivery of technology-enabled psychedelic therapies. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-02-18. Through its Field Trip Discovery, the Company develops psychedelic molecules and conducts research on plant-based psychedelics. Field Trip Discovery focuses on developing medicines targeting the serotonin 5HT2A serotonin receptors. Its Field Trip Health division operates clinics across North America and Europe providing Ketamine-assisted psychotherapy (KAT) under various programs. Through its Field Trip Digital, it builds the digital and technological tools to support psychedelic experiences and consciousness expansion. The firm provides Trip and Portal applications. Its Trip is an iOS and Android application for consciousness expansion. Its Portal is a digital health platform for clients participating in psychedelic therapies at Field Trip Health centers.
See Also
What is Field Trip Health Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
63.7m
CAD
Based on the financial report for Mar 31, 2022, Field Trip Health Ltd's Cash & Cash Equivalents amounts to 63.7m CAD.
What is Field Trip Health Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
71%
Over the last year, the Cash & Cash Equivalents growth was 66%. The average annual Cash & Cash Equivalents growth rates for Field Trip Health Ltd have been 374% over the past three years , and 71% over the past ten years .
